Clinical trial
A Comparative Study of Haploidentical Transplantation Supported by Third-party Cord Blood and Haploidentical Transplantation in Hematological Malignancies
NCT05290545 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Comparative Study of Haploidentical Transplantation Supported by Third-party Cord Blood and Haploidentical Transplantation in Hematological Malignancies
- Lead sponsor
- Nanfang Hospital, Southern Medical University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 15, 2022
- Completion date
- March 30, 2024
- Enrollment
- 314 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hematological malignancies, hematopoietic stem cell transplantation